Real-World Comparison of Major Bleeding and Associated Costs Among Treatment-Naïve Nonvalvular Atrial Fibrillation Patients Initiating Apixaban or Warfarin
Loading...
Date
2016
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Open Access Color
OpenAIRE Downloads
OpenAIRE Views
Abstract
...
Description
Onur Başer (MEF Author)
##nofulltext##
##nofulltext##
Keywords
Fields of Science
Citation
Amin A, Keshishian A, Xie L, Baser O, Price K, Vo L, Mardekian J, Mendoza M, Singhal S, Patel C, Odell K, Trocio J. (August 27-31 , 2016). Real-world comparison of major bleeding and associated costs among treatment-naïve nonvalvular atrial fibrillation patients initiating apixaban or warfarin. European Society of Cardiology (ESC) Congress 2016. Rome, Italy.
WoS Q
Scopus Q
Source
European Society of Cardiology (ESC) Congress 2016
